Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Washington, DC
SEC filing record 1 source field available
Fiscal year end
31 December
Vanda Pharmaceuticals Inc. has filed 1,327 SEC EDGAR filings since 29 Dec 2005

SEC filing history

Showing 601-625 of 954 matching filings.

Per page
25
Current page
25
4

FORM 4 SUBMISSION

Filing date
06 Jan 2016
Reporting date
04 Jan 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
06 Jan 2016
Reporting date
04 Jan 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
06 Jan 2016
Reporting date
04 Jan 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-34186

8-K

Filing date
22 Dec 2015
Reporting date
22 Dec 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
21 Dec 2015
Reporting date
17 Dec 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
21 Dec 2015
Reporting date
17 Dec 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-34186

FORM 8-K

Filing date
21 Dec 2015
Reporting date
17 Dec 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
18 Dec 2015
Reporting date
16 Dec 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
4/A

OWNERSHIP DOCUMENT

Filing date
18 Dec 2015
Reporting date
09 Dec 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
11 Dec 2015
Reporting date
09 Dec 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-34186

FORM 8-K

Filing date
23 Nov 2015
Reporting date
19 Nov 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-34186

8-K

Filing date
03 Nov 2015
Reporting date
03 Nov 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-34186

FORM 8-K

Filing date
14 Oct 2015
Reporting date
13 Oct 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
15 Sep 2015
Reporting date
14 Sep 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
15 Sep 2015
Reporting date
14 Sep 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-34186

FORM 8-K

Filing date
15 Sep 2015
Reporting date
15 Sep 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
11 Sep 2015
Reporting date
09 Sep 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
09 Sep 2015
Reporting date
08 Sep 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
09 Sep 2015
Reporting date
08 Sep 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-34186

8-K

Filing date
29 Jul 2015
Reporting date
29 Jul 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-205513

EFFECT filing

Filing date
21 Jul 2015
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
17 Jul 2015
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD

UPLOAD filing

Filing date
16 Jul 2015
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .